Credit Suisse’s Sarepta Therapeutics SRPT Stock Holding History

Credit Suisse’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$22.8M	Buy	176,136 +8,399	+5%	+$1.09M	0.02%	597
2023 Q4	$16.2M	Buy	167,737 +27,838	+20%	+$2.68M	0.02%	718
2023 Q3	$17M	Sell	139,899 -84,932	-38%	-$10.3M	0.02%	681
2023 Q2	$25.7M	Buy	224,831 +31,659	+16%	+$3.63M	0.03%	579
2023 Q1	$26.6M	Sell	193,172 -82,507	-30%	-$11.4M	0.03%	574
2022 Q4	$35.7M	Sell	275,679 -11,552	-4%	-$1.5M	0.04%	486
2022 Q3	$31.8M	Sell	287,231 -120,209	-30%	-$13.3M	0.04%	511
2022 Q2	$30.5M	Sell	407,440 -190,722	-32%	-$14.3M	0.03%	541
2022 Q1	$46.7M	Sell	598,162 -233,036	-28%	-$18.2M	0.04%	458
2021 Q4	$74.8M	Sell	831,198 -4,927	-0.6%	-$444K	0.04%	335
2021 Q3	$77.3M	Buy	836,125 +199,721	+31%	+$18.5M	0.04%	332
2021 Q2	$49.5M	Buy	636,404 +30,554	+5%	+$2.38M	0.03%	509
2021 Q1	$45.2M	Buy	605,850 +132,009	+28%	+$9.84M	0.02%	562
2020 Q4	$80.8M	Buy	473,841 +69,756	+17%	+$11.9M	0.04%	344
2020 Q3	$56.7M	Buy	404,085 +1,736	+0.4%	+$244K	0.03%	394
2020 Q2	$64.5M	Buy	402,349 +8,157	+2%	+$1.31M	0.05%	337
2020 Q1	$38.6M	Sell	394,192 -21,979	-5%	-$2.15M	0.03%	421
2019 Q4	$53.7M	Buy	416,171 +75,541	+22%	+$9.75M	0.04%	387
2019 Q3	$25.7M	Buy	340,630 +66,697	+24%	+$5.02M	0.02%	589
2019 Q2	$41.6M	Buy	273,933 +31,581	+13%	+$4.8M	0.04%	405
2019 Q1	$28.9M	Buy	242,352 +15,963	+7%	+$1.9M	0.03%	513
2018 Q4	$24.7M	Sell	226,389 -8,548	-4%	-$933K	0.03%	559
2018 Q3	$37.9M	Buy	234,937 +42,681	+22%	+$6.89M	0.03%	449
2018 Q2	$25.4M	Sell	192,256 -192,475	-50%	-$25.4M	0.02%	595
2018 Q1	$28.5M	Buy	384,731 +164,778	+75%	+$12.2M	0.03%	573
2017 Q4	$12.2M	Buy	219,953 +133,001	+153%	+$7.4M	0.01%	924
2017 Q3	$3.94M	Sell	86,952 -3,307	-4%	-$150K	﹤0.01%	1607
2017 Q2	$3.04M	Sell	90,259 -96,036	-52%	-$3.24M	﹤0.01%	1647
2017 Q1	$5.52M	Buy	186,295 +112,899	+154%	+$3.34M	0.01%	1359
2016 Q4	$2.01M	Sell	73,396 -4,116	-5%	-$113K	﹤0.01%	2141
2016 Q3	$4.76M	Buy	77,512 +14,686	+23%	+$902K	﹤0.01%	1475
2016 Q2	$1.2M	Sell	62,826 -389,984	-86%	-$7.44M	﹤0.01%	2510
2016 Q1	$8.84M	Buy	452,810 +377,537	+502%	+$7.37M	0.01%	1063
2015 Q4	$2.9M	Sell	75,273 -28,691	-28%	-$1.11M	﹤0.01%	1860
2015 Q3	$3.34M	Sell	103,964 -36,900	-26%	-$1.19M	﹤0.01%	1749
2015 Q2	$4.29M	Buy	140,864 +34,916	+33%	+$1.06M	﹤0.01%	1706
2015 Q1	$1.41M	Sell	105,948 -43,799	-29%	-$582K	﹤0.01%	2465
2014 Q4	$2.17M	Buy	149,747 +40,840	+37%	+$591K	﹤0.01%	2174
2014 Q3	$2.3M	Buy	108,907 +30,602	+39%	+$646K	﹤0.01%	2060
2014 Q2	$2.33M	Buy	78,305 +14,779	+23%	+$440K	﹤0.01%	2235
2014 Q1	$1.53M	Sell	63,526 -72,750	-53%	-$1.75M	﹤0.01%	2426
2013 Q4	$2.78M	Buy	136,276 +72,919	+115%	+$1.49M	﹤0.01%	2038
2013 Q3	$2.99M	Buy	63,357 +12,053	+23%	+$569K	﹤0.01%	1751
2013 Q2	$1.95M	Buy	+51,304	New	+$1.95M	﹤0.01%	1965